All Articles tagged non-muscle invasive bladder cancer
Oncology
October 28, 2024 EDT This study evaluated the adequacy of first-line intravesical BCG treatment among high-risk NMIBC patients in the United States, including the subgroup with carcinoma in situ (CIS) of the bladder.